Insider Trading History of Bhonsle Sunil

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Bhonsle Sunil since 2005. The trader's CIK number is 1180755. At the time of the last reporting, Bhonsle Sunil was the Executive VP and COO of Titan Pharmaceuticals Inc. (stock ticker symbol TTNP). Also see all insider trading activities at Titan Pharmaceuticals Inc.


Yearly summary of insider trading at Titan Pharmaceuticals Inc (TTP) by Bhonsle Sunil

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 TTP 300,000 $75,000 0 $0 0 $0
2016 TTP 44,604 $161,314 0 $0 0 $0
2015 TTP 61,610 $47,833 0 $0 0 $0
2014 TTP 216,000 $102,728 0 $0 0 $0
2013 TTP 50,000 $22,750 0 $0 50,000 $75,000
2011 TTP 25,000 $32,900 0 $0 0 $0
2008 TTP 20,000 $25,000 0 $0 0 $0
2007 TTP 21,100 $42,530 0 $0 0 $0
2005 TTP 52,300 $79,096 0 $0 0 $0


Insider trading of Titan Pharmaceuticals Inc (TTP) by Bhonsle Sunil

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-09-21 TTP Buy 300,000 .25 75,000
2016-07-18 TTNP Buy 10,000 4.96 49,550
2016-02-22 TTNP Buy 11,763 3.56 41,817
2016-01-15 TTNP Buy 5,841 2.72 15,887
2016-01-11 TTNP.OB Buy 17,000 3.18 54,060
2015-10-01 TTNP.OB Buy 200 3.99 798
2015-09-30 TTNP.OB Buy 500 3.98 1,990
2015-09-28 TTNP.OB Buy 910 3.62 3,296
2015-09-15 TTNP.OB Buy 5,000 .69 3,449
2015-09-16 TTNP.OB Buy 5,000 .70 3,500
2015-08-25 TTNP.OB Buy 50,000 .70 34,800
2014-10-13 TTNP.OB Buy 92,000 .47 43,240
2014-10-09 TTNP.OB Buy 100,000 .48 47,800
2014-10-10 TTNP.OB Buy 24,000 .49 11,688
2013-06-18 TTNP.OB Buy 50,000 .46 22,750
2013-02-25 TTNP.OB Option Ex 50,000 1.50 75,000
2011-11-18 TTNP.OB Buy 25,000 1.32 32,900
2008-02-11 AMEX - TTP Buy 20,000 1.25 25,000
2007-05-22 AMEX - TTP Buy 15,000 2.02 30,300
2007-05-17 AMEX - TTP Buy 6,100 2.00 12,230
2005-11-07 TTP Buy 30,000 1.45 43,500
2005-08-16 TTP Buy 2,500 2.20 5,500
2005-11-03 TTP Buy 9,900 1.52 15,048
2005-11-03 TTP Buy 9,900 1.52 15,048

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bhonsle Sunil (Executive VP and COO of Titan Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.